NASDAQ:SINT - Nasdaq - US8293927039 - Common Stock - Currency: USD
5.31
+0.51 (+10.62%)
The current stock price of SINT is 5.31 USD. In the past month the price increased by 65.42%. In the past year, price decreased by -81.2%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
SINTX Technologies Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Salt Lake City, Utah and currently employs 43 full-time employees. The company went IPO on 2014-02-11. SINTX Technologies, Inc. is an advanced ceramics company. The firm is focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. The firm is focusing primarily on the research, development and commercialization of medical devices manufactured with silicon nitride. The firm is manufacturing, research, and development of products comprised from advanced ceramic materials for external partners. The company produces silicon nitride for use in its commercial products and product candidates in various forms: solid silicon nitride, porous silicon nitride, silicon nitride powder, composites of silicon nitride and PEEK and PEKK and silicon nitride coating. The company is also focused on development and manufacturing ceramics for personnel, aircraft, and vehicle armor. Its silicon nitride products can be polished to a smooth and wear-resistant surface for articulating applications, such as bearings for hip and knee replacements.
SINTX TECHNOLOGIES INC
1885 West 2100 Street
Salt Lake City UTAH 84119 US
CEO: B. Sonny Bal
Employees: 43
Company Website: https://sintx.com/
Investor Relations: http://investors.amedica.com/
Phone: 18018393516
The current stock price of SINT is 5.31 USD. The price increased by 10.62% in the last trading session.
The exchange symbol of SINTX TECHNOLOGIES INC is SINT and it is listed on the Nasdaq exchange.
SINT stock is listed on the Nasdaq exchange.
6 analysts have analysed SINT and the average price target is 71.4 USD. This implies a price increase of 1244.63% is expected in the next year compared to the current price of 5.31. Check the SINTX TECHNOLOGIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SINTX TECHNOLOGIES INC (SINT) has a market capitalization of 7.12M USD. This makes SINT a Nano Cap stock.
SINTX TECHNOLOGIES INC (SINT) currently has 43 employees.
SINTX TECHNOLOGIES INC (SINT) has a support level at 2.86 and a resistance level at 5.32. Check the full technical report for a detailed analysis of SINT support and resistance levels.
The Revenue of SINTX TECHNOLOGIES INC (SINT) is expected to grow by 23.6% in the next year. Check the estimates tab for more information on the SINT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SINT does not pay a dividend.
SINTX TECHNOLOGIES INC (SINT) will report earnings on 2025-05-12.
SINTX TECHNOLOGIES INC (SINT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-93.14).
The outstanding short interest for SINTX TECHNOLOGIES INC (SINT) is 2.62% of its float. Check the ownership tab for more information on the SINT short interest.
ChartMill assigns a technical rating of 6 / 10 to SINT. When comparing the yearly performance of all stocks, SINT is a bad performer in the overall market: 92.92% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to SINT. SINT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months SINT reported a non-GAAP Earnings per Share(EPS) of -93.14. The EPS increased by 98.77% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -103.07% | ||
ROE | -208.74% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 43% to SINT. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 97.87% and a revenue growth 23.6% for SINT